Çà¹âÑÛÊǵڶþ´óÖÂäÐÔÑÛ²¡£¬ÊÓÍøÄ¤Éñ¾­Ñ×Ö¢ÔÚÊÓÍøÄ¤Éñ¾­½Úϸ°ûËðÉËÖз¢»ÓÓÐÖØÒª×÷Ó㬵«Æä»úÖÆÉÐδÍêÈ«²ûÃ÷¡£¸´µ©´óѧÄÔ¿ÆÑ§Ñо¿Ôº/ҽѧÉñ¾­ÉúÎïѧ¹ú¼ÒÖØµãʵÑéÊÒÍõÖзå½ÌÊÚ¿ÎÌâ×éºÍ¸½ÊôÑÛ¶ú±Çºí¿ÆÒ½ÔºÑÛ¿ÆËïÐË»³½ÌÊÚ¿ÎÌâ×éͨÁ¦ºÏ×÷£¬¾­¹ý3Äê¶àµÄDZÐÄÑо¿£¬ÔÚÖ×Áö»µËÀÒò×Ó-¦Á£¨TNF-¦Á£©ÓÕµ¼ÊÓÍøÄ¤Éñ¾­½Úϸ°ûµòÍö»úÖÆ·½ÃæÈ¡µÃеÄÑо¿½øÕ¹£¬³É¹ûÒÔ¡¶TNF-¦Áͨ¹ýÔöÇ¿Nav1.6ͨµÀÓÕµ¼ÊÓÍøÄ¤Éñ¾­½Úϸ°û³¬ÐË·ÜÐÔµ¼ÖÂÆäÔÚʵÑéÐÔÇà¹âÑÛÖеĵòÍö¡·£¨Soluble tumor necrosis factor-alpha induced hyperexcitability contributes to retinal ganglion cell apoptosis by enhancing Nav1.6 in experimental glaucoma£©ÎªÌâÔÚÏß·¢±íÓÚ¡¶Éñ¾­Ñ×Ö¢ÔÓÖ¾¡·£¨Journal of Neuroinflammation£©ÉÏ¡£

TNF-¦ÁÊÇÇà¹âÑÛÊÓÍøÄ¤ÖÐ×îÖ÷ÒªµÄÉñ¾­Ñ×Ö¢½éÖÊ¡£ÍõÖзå½ÌÊÚÍŶÓÔËÓÃĤƬǯµçÉúÀí¡¢ÃâÒßÓ«¹âȾɫ¡¢TUNEL¼ì²â¡¢²£Á§ÌåÇ»×¢ÉäµÈ¼¼Êõ£¬Ì½¾¿ÁËTNF-¦Á½éµ¼ÊÓÍøÄ¤Éñ¾­½Úϸ°ûµòÍöµÄ¾ßÌå»úÖÆ¡£Ñо¿·¢ÏÖ£¬TNF-¦Áͨ¹ý½áºÏTNFR1ÊÜÌåÏÔÖøÔöÇ¿ÊÓÍøÄ¤Éñ¾­½Úϸ°ûÉÏNav1.6ͨµÀµÄ¹¦Äܺͱí´ïÁ¿£¬½ø¶øÓÕµ¼Éñ¾­½Úϸ°û³¬ÐË·ÜÐÔ£¬×îÖÕµ¼ÖÂÆäµòÍöÐÔËÀÍö¡£²£Á§ÌåÇ»×¢ÉäTNF-¦Á×è¶Ï¼Á¿ÉÒÔÓÐЧ±£»¤ÂýÐÔ¸ßÑÛѹģÐÍÖеÄÊÓÍøÄ¤Éñ¾­½Úϸ°û¡£±¾½á¹ûΪÁÙ´²ÖÐÔËÓÃTNF-¦Á¼°Nav1.6×è¶Ï¼ÁÖÎÁÆÇà¹âÑÛÌṩÁËеÄÀíÂÛÒÀ¾Ý¡£

¶àÄêÀ´ÓÉÑîÐÛÀïԺʿÁìÏεĸ´µ©´óѧÄÔ¿ÆÑ§Ñо¿ÔºÊÓÍøÄ¤Ñо¿ÊҺ͸½ÊôÒ½Ôº×¢ÖØ»ù´¡Ñо¿ÓëÁÙ´²µÄ½áºÏ£¬²»¶ÏÈ¡µÃ½øÕ¹£¬´Ó¶ø»ñµÃÁ˹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØ´óÏîÄ¿¡°Éñ¾­ÐÔÊÓ¾õËðÉ˼°ÐÞ¸´µÄ»úÖÆ¡±£¬ÍõÖзåÑо¿Ô±¿ÎÌâ×éµÄÊǸÃÖØ´óÏîÄ¿ÖØÒª×é³É²¿·Ö¡£ÕâÒ»Ñо¿³É¹ûÖ÷ÒªÓÉÍõÖзå½ÌÊÚºÍËïÐË»³½ÌÊÚÁªºÏÅàÑøµÄÖ±²©Éú³Ì˶£¨ÂÛÎĵĵÚÒ»×÷Õߣ©Íê³É£¬ÍõÖзå½ÌÊÚºÍËïÐË»³½ÌÊÚΪ¸ÃÂÛÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£Ñо¿µÃµ½¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÖØ´óÏîÄ¿¡¢ÉϺ£ÊпƼ¼ÖØ´óרÏîºÍÕŽ­ÊµÑéÊÒµÈ×ÊÖú¡£